Green tea polyphenol alpha secretase enhancers and methods of use
AssigneeUniversity of South Florida
InventorsROLAND DOUGLAS SHYTLE, JUN TAN
Life of this patent
Estimating the term…
Loading patent…
AssigneeUniversity of South Florida
InventorsROLAND DOUGLAS SHYTLE, JUN TAN
Estimating the term…
The subject invention concerns materials and methods for treating or preventing a neurodegenerative condition or disease associated with β-amyloid peptide deposition in neural tissue in a person or animal by administering a therapeutically effective amount of a polyphenol, or an analog, isomer, metabolite, or prodrug thereof, that increases expression or activity of a protein that exhibits α-secretase activity. The subject invention also provides methods to increase α-secretase expression and/or activity in cells by administering polyphenol flavonoids like (−)-epigallocatechin-3-gallate (EGCG) and epicatechin (EC), two polyphenols derived from green tea and other plants and that can be produced synthetically. Furthermore, there are provided methods to decrease or inhibit the production of Aβ1-40 or Aβ1-42 by administering the EGCG and EC compounds, their analogs, metabolites, and prodrugs.
A method for:
The method according to claim, 1 wherein the method further comprises identifying a person or animal afflicted with or at risk of developing said neurodegenerative disease or condition.
A method for:
A composition comprising a polyphenol, or an analog, isomer, metabolite, or prodrug thereof, that increases expression or activity of a protein having α-secretase enzymatic activity, and, optionally, an agent or compound that inhibits or decreases expression or levels of protein having β-secretase enzymatic activity or γ-secretase enzymatic activity, and, optionally, a pharmaceutically acceptable carrier or diluent.
Dependencies are inferred from the claim text.